CI Investments Inc’s AstraZeneca AZN Stock Holding History

CI Investments Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Buy	+81,017	New	+$15.2M	0.05%	224
2026 Q1	–	Sell	-110,835	Closed	-$20.4M	–	620
2025 Q4	$20.4M	Sell	110,835 -8,620	-7%	-$1.51M	0.09%	171
2025 Q3	$18.3M	Sell	119,455 -71,723	-38%	-$10.9M	0.07%	182
2025 Q2	$26.7M	Sell	191,178 -96,293	-33%	-$13.5M	0.1%	154
2025 Q1	$42.3M	Sell	287,471 -1,959	-0.7%	-$283K	0.18%	109
2024 Q4	$37.9M	Buy	289,430 +8,815	+3%	+$1.23M	0.14%	127
2024 Q3	$43.7M	Buy	+280,615	New	+$45.3M	0.17%	120

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CI Investments Inc's AZN Position: Q2 2026 in Review

CI Investments Inc opened a new position in AstraZeneca (AZN) in Q2 2026: 81,017 shares worth $15.4M. The stake represents 0.05% of the portfolio and ranks #224 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in AZN as recently as Q4 2025.

CI Investments Inc first reported a position in AZN in Q3 2024 and has held it in 7 quarters since. The position peaked at $43.7M in Q3 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

CI Investments Inc held 81,017 shares of AstraZeneca worth $15.4M as of Q2 2026.
AstraZeneca was a new CI Investments Inc position in Q2 2026.
AstraZeneca made up 0.05% of CI Investments Inc's portfolio in Q2 2026, its #224 holding.
CI Investments Inc first reported a position in AstraZeneca in Q3 2024 and has held it in 7 quarters since.
CI Investments Inc's AstraZeneca position peaked at $43.7M in Q3 2024.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.